Global Injectable Drug Delivery Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 30-Sep-2022
No. of pages: 103
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Injectable Drug Delivery companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Injectable Drug Delivery market. Further, it explains the major drivers and regional dynamics of the global Injectable Drug Delivery market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Baxter

- Becton, Dickinson

- Gerresheimer

- Pfizer

- Schott

- ELI Lilly

- Novartis

- Terumo

- Teva Pharmaceutical

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Injectable Drug Delivery Segment by Type

- Skin Injection

- Circulatory/Musculoskeletal Injection

- Organs Injection

- Central Nervous System Injection

Injectable Drug Delivery Segment by Application

- Hospitals & Clinics

- Home Care Settings

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Injectable Drug Delivery market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Injectable Drug Delivery market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Injectable Drug Delivery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Injectable Drug Delivery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Injectable Drug Delivery revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Injectable Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Injectable Drug Delivery revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Baxter, Becton, Dickinson, Gerresheimer, Pfizer, Schott, ELI Lilly, Novartis, Terumo and Teva Pharmaceutical, etc.

Global Injectable Drug Delivery Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Skin Injection
1.2.3 Circulatory/Musculoskeletal Injection
1.2.4 Organs Injection
1.2.5 Central Nervous System Injection
1.3 Market by Application
1.3.1 Global Injectable Drug Delivery Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals & Clinics
1.3.3 Home Care Settings
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Injectable Drug Delivery Market Size (2017-2028)
2.2 Injectable Drug Delivery Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Injectable Drug Delivery Market Size by Region (2017-2022)
2.4 Global Injectable Drug Delivery Market Size Forecast by Region (2023-2028)
2.5 Global Top Injectable Drug Delivery Countries Ranking by Market Size
3 Injectable Drug Delivery Competitive by Company
3.1 Global Injectable Drug Delivery Revenue by Players
3.1.1 Global Injectable Drug Delivery Revenue by Players (2017-2022)
3.1.2 Global Injectable Drug Delivery Market Share by Players (2017-2022)
3.2 Global Injectable Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Injectable Drug Delivery Revenue
3.4 Global Injectable Drug Delivery Market Concentration Ratio
3.4.1 Global Injectable Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Drug Delivery Revenue in 2021
3.5 Global Injectable Drug Delivery Key Players Head office and Area Served
3.6 Key Players Injectable Drug Delivery Product Solution and Service
3.7 Date of Enter into Injectable Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Injectable Drug Delivery Breakdown Data by Type
4.1 Global Injectable Drug Delivery Historic Revenue by Type (2017-2022)
4.2 Global Injectable Drug Delivery Forecasted Revenue by Type (2023-2028)
5 Global Injectable Drug Delivery Breakdown Data by Application
5.1 Global Injectable Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Injectable Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Injectable Drug Delivery Revenue by Company (2020-2022)
6.2 North America Injectable Drug Delivery Revenue by Type (2017-2028)
6.3 North America Injectable Drug Delivery Revenue by Application (2017-2028)
6.4 North America Injectable Drug Delivery Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Injectable Drug Delivery Revenue by Company (2020-2022)
7.2 Europe Injectable Drug Delivery Revenue by Type (2017-2028)
7.3 Europe Injectable Drug Delivery Revenue by Application (2017-2028)
7.4 Europe Injectable Drug Delivery Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Injectable Drug Delivery Revenue by Company (2020-2022)
8.2 Asia Pacific Injectable Drug Delivery Revenue by Type (2017-2028)
8.3 Asia Pacific Injectable Drug Delivery Revenue by Application (2017-2028)
8.4 Asia Pacific Injectable Drug Delivery Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Injectable Drug Delivery Revenue by Company (2020-2022)
9.2 Latin America Injectable Drug Delivery Revenue by Type (2017-2028)
9.3 Latin America Injectable Drug Delivery Revenue by Application (2017-2028)
9.4 Latin America Injectable Drug Delivery Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Injectable Drug Delivery Revenue by Company (2020-2022)
10.2 Middle East and Africa Injectable Drug Delivery Revenue by Type (2017-2028)
10.3 Middle East and Africa Injectable Drug Delivery Revenue by Application (2017-2028)
10.4 Middle East and Africa Injectable Drug Delivery Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Company Details
11.1.2 Baxter Business Overview
11.1.3 Baxter Injectable Drug Delivery Products and Services
11.1.4 Baxter Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022)
11.1.5 Baxter Injectable Drug Delivery SWOT Analysis
11.1.6 Baxter Recent Developments
11.2 Becton, Dickinson
11.2.1 Becton, Dickinson Company Details
11.2.2 Becton, Dickinson Business Overview
11.2.3 Becton, Dickinson Injectable Drug Delivery Products and Services
11.2.4 Becton, Dickinson Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022)
11.2.5 Becton, Dickinson Injectable Drug Delivery SWOT Analysis
11.2.6 Becton, Dickinson Recent Developments
11.3 Gerresheimer
11.3.1 Gerresheimer Company Details
11.3.2 Gerresheimer Business Overview
11.3.3 Gerresheimer Injectable Drug Delivery Products and Services
11.3.4 Gerresheimer Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022)
11.3.5 Gerresheimer Injectable Drug Delivery SWOT Analysis
11.3.6 Gerresheimer Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Injectable Drug Delivery Products and Services
11.4.4 Pfizer Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022)
11.4.5 Pfizer Injectable Drug Delivery SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 Schott
11.5.1 Schott Company Details
11.5.2 Schott Business Overview
11.5.3 Schott Injectable Drug Delivery Products and Services
11.5.4 Schott Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022)
11.5.5 Schott Injectable Drug Delivery SWOT Analysis
11.5.6 Schott Recent Developments
11.6 ELI Lilly
11.6.1 ELI Lilly Company Details
11.6.2 ELI Lilly Business Overview
11.6.3 ELI Lilly Injectable Drug Delivery Products and Services
11.6.4 ELI Lilly Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022)
11.6.5 ELI Lilly Injectable Drug Delivery SWOT Analysis
11.6.6 ELI Lilly Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Injectable Drug Delivery Products and Services
11.7.4 Novartis Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022)
11.7.5 Novartis Injectable Drug Delivery SWOT Analysis
11.7.6 Novartis Recent Developments
11.8 Terumo
11.8.1 Terumo Company Details
11.8.2 Terumo Business Overview
11.8.3 Terumo Injectable Drug Delivery Products and Services
11.8.4 Terumo Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022)
11.8.5 Terumo Injectable Drug Delivery SWOT Analysis
11.8.6 Terumo Recent Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Details
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Injectable Drug Delivery Products and Services
11.9.4 Teva Pharmaceutical Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022)
11.9.5 Teva Pharmaceutical Injectable Drug Delivery SWOT Analysis
11.9.6 Teva Pharmaceutical Recent Developments
12 Injectable Drug Delivery Market Dynamics
12.1 Injectable Drug Delivery Market Trends
12.2 Injectable Drug Delivery Market Drivers
12.3 Injectable Drug Delivery Market Challenges
12.4 Injectable Drug Delivery Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Injectable Drug Delivery Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Skin Injection
Table 3. Key Players of Circulatory/Musculoskeletal Injection
Table 4. Key Players of Organs Injection
Table 5. Key Players of Central Nervous System Injection
Table 6. Global Injectable Drug Delivery Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Injectable Drug Delivery Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Injectable Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Injectable Drug Delivery Revenue Market Share by Region (2017-2022)
Table 10. Global Injectable Drug Delivery Revenue by Players (2017-2022) & (US$ Million)
Table 11. Global Injectable Drug Delivery Market Share by Players (2017-2022)
Table 12. Global Top Injectable Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Drug Delivery as of 2021)
Table 13. Ranking of Global Top Injectable Drug Delivery Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Injectable Drug Delivery Revenue (CR5 and HHI) & (2017-2022)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Injectable Drug Delivery Product Solution and Service
Table 17. Date of Key Manufacturers Enter into Injectable Drug Delivery Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Injectable Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Injectable Drug Delivery Revenue Market Share by Type (2017-2022)
Table 21. Global Injectable Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Injectable Drug Delivery Revenue Market Share by Type (2023-2028)
Table 23. Global Injectable Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Injectable Drug Delivery Revenue Market Share by Application (2017-2022)
Table 25. Global Injectable Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Injectable Drug Delivery Revenue Market Share by Application (2023-2028)
Table 27. North America Injectable Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 28. North America Injectable Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 29. North America Injectable Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 30. North America Injectable Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 31. North America Injectable Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 32. North America Injectable Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 33. North America Injectable Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 34. Europe Injectable Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 35. Europe Injectable Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 36. Europe Injectable Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 37. Europe Injectable Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 38. Europe Injectable Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 39. Europe Injectable Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 40. Europe Injectable Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 41. Asia Pacific Injectable Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 42. Asia Pacific Injectable Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 43. Asia Pacific Injectable Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 44. Asia Pacific Injectable Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 45. Asia Pacific Injectable Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 46. Asia Pacific Injectable Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 47. Asia Pacific Injectable Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
Table 48. Latin America Injectable Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 49. Latin America Injectable Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 50. Latin America Injectable Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 51. Latin America Injectable Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 52. Latin America Injectable Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 53. Latin America Injectable Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 54. Latin America Injectable Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Injectable Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 56. Middle East and Africa Injectable Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Injectable Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Injectable Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Injectable Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Injectable Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Injectable Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 62. Baxter Company Details
Table 63. Baxter Business Overview
Table 64. Baxter Injectable Drug Delivery Product and Services
Table 65. Baxter Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022) & (US$ Million)
Table 66. Baxter Injectable Drug Delivery SWOT Analysis
Table 67. Baxter Recent Developments
Table 68. Becton, Dickinson Company Details
Table 69. Becton, Dickinson Business Overview
Table 70. Becton, Dickinson Injectable Drug Delivery Product and Services
Table 71. Becton, Dickinson Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022) & (US$ Million)
Table 72. Becton, Dickinson Injectable Drug Delivery SWOT Analysis
Table 73. Becton, Dickinson Recent Developments
Table 74. Gerresheimer Company Details
Table 75. Gerresheimer Business Overview
Table 76. Gerresheimer Injectable Drug Delivery Product and Services
Table 77. Gerresheimer Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022) & (US$ Million)
Table 78. Gerresheimer Injectable Drug Delivery SWOT Analysis
Table 79. Gerresheimer Recent Developments
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Injectable Drug Delivery Product and Services
Table 83. Pfizer Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022) & (US$ Million)
Table 84. Pfizer Injectable Drug Delivery SWOT Analysis
Table 85. Pfizer Recent Developments
Table 86. Schott Company Details
Table 87. Schott Business Overview
Table 88. Schott Injectable Drug Delivery Product and Services
Table 89. Schott Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022) & (US$ Million)
Table 90. Schott Injectable Drug Delivery SWOT Analysis
Table 91. Schott Recent Developments
Table 92. ELI Lilly Company Details
Table 93. ELI Lilly Business Overview
Table 94. ELI Lilly Injectable Drug Delivery Product and Services
Table 95. ELI Lilly Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022) & (US$ Million)
Table 96. ELI Lilly Injectable Drug Delivery SWOT Analysis
Table 97. ELI Lilly Recent Developments
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Injectable Drug Delivery Product and Services
Table 101. Novartis Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022) & (US$ Million)
Table 102. Novartis Injectable Drug Delivery SWOT Analysis
Table 103. Novartis Recent Developments
Table 104. Terumo Company Details
Table 105. Terumo Business Overview
Table 106. Terumo Injectable Drug Delivery Product and Services
Table 107. Terumo Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022) & (US$ Million)
Table 108. Terumo Injectable Drug Delivery SWOT Analysis
Table 109. Terumo Recent Developments
Table 110. Teva Pharmaceutical Company Details
Table 111. Teva Pharmaceutical Business Overview
Table 112. Teva Pharmaceutical Injectable Drug Delivery Product and Services
Table 113. Teva Pharmaceutical Injectable Drug Delivery Revenue in Injectable Drug Delivery Business (2017-2022) & (US$ Million)
Table 114. Teva Pharmaceutical Injectable Drug Delivery SWOT Analysis
Table 115. Teva Pharmaceutical Recent Developments
Table 116. Injectable Drug Delivery Market Trends
Table 117. Injectable Drug Delivery Market Drivers
Table 118. Injectable Drug Delivery Market Challenges
Table 119. Injectable Drug Delivery Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injectable Drug Delivery Sales Market Share by Type: 2021 VS 2028
Figure 2. Skin Injection Features
Figure 3. Circulatory/Musculoskeletal Injection Features
Figure 4. Organs Injection Features
Figure 5. Central Nervous System Injection Features
Figure 6. Global Injectable Drug Delivery Sales Market Share by Application: 2021 VS 2028
Figure 7. Hospitals & Clinics Case Studies
Figure 8. Home Care Settings Case Studies
Figure 9. Others Case Studies
Figure 10. Injectable Drug Delivery Report Years Considered
Figure 11. Global Injectable Drug Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Injectable Drug Delivery Market Size 2017-2028 (US$ Million)
Figure 13. Global Injectable Drug Delivery Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Injectable Drug Delivery Revenue Market Share by Region in 2017 VS 2022
Figure 15. Global Top 10 Injectable Drug Delivery Countries Ranking by Market Size (US$ Million) in 2021
Figure 16. Global Injectable Drug Delivery Market Share by Players in 2021
Figure 17. Global Top Injectable Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Drug Delivery as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Injectable Drug Delivery Revenue in 2021
Figure 19. North America Injectable Drug Delivery Revenue Market Share by Company in 2021
Figure 20. North America Injectable Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 21. North America Injectable Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 22. North America Injectable Drug Delivery Revenue Share by Country (2017-2028)
Figure 23. U.S. Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 24. Canada Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 25. Europe Injectable Drug Delivery Revenue Market Share by Company in 2021
Figure 26. Europe Injectable Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 27. Europe Injectable Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 28. Europe Injectable Drug Delivery Revenue Share by Country (2017-2028)
Figure 29. Germany Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 30. France Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 31. U.K. Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 32. Italy Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 33. Russia Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Injectable Drug Delivery Revenue Market Share by Company in 2021
Figure 35. Asia Pacific Injectable Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 36. Asia Pacific Injectable Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 37. Asia Pacific Injectable Drug Delivery Revenue Share by Region (2017-2028)
Figure 38. China Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 39. Japan Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 40. South Korea Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 41. India Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 42. Australia Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 43. Taiwan Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 44. Indonesia Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 45. Thailand Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 46. Malaysia Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 47. Philippines Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 48. Vietnam Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 49. Latin America Injectable Drug Delivery Revenue Market Share by Company in 2021
Figure 50. Latin America Injectable Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 51. Latin America Injectable Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 52. Latin America Injectable Drug Delivery Revenue Share by Country (2017-2028)
Figure 53. Mexico Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 54. Brazil Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 55. Argentina Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 56. Middle East and Africa Injectable Drug Delivery Revenue Market Share by Company in 2021
Figure 57. Middle East and Africa Injectable Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 58. Middle East and Africa Injectable Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 59. Middle East and Africa Injectable Drug Delivery Revenue Share by Country (2017-2028)
Figure 60. Turkey Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 61. Saudi Arabia Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 62. U.A.E Injectable Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 63. Baxter Revenue Growth Rate in Injectable Drug Delivery Business (2017-2022)
Figure 64. Becton, Dickinson Revenue Growth Rate in Injectable Drug Delivery Business (2017-2022)
Figure 65. Gerresheimer Revenue Growth Rate in Injectable Drug Delivery Business (2017-2022)
Figure 66. Pfizer Revenue Growth Rate in Injectable Drug Delivery Business (2017-2022)
Figure 67. Schott Revenue Growth Rate in Injectable Drug Delivery Business (2017-2022)
Figure 68. ELI Lilly Revenue Growth Rate in Injectable Drug Delivery Business (2017-2022)
Figure 69. Novartis Revenue Growth Rate in Injectable Drug Delivery Business (2017-2022)
Figure 70. Terumo Revenue Growth Rate in Injectable Drug Delivery Business (2017-2022)
Figure 71. Teva Pharmaceutical Revenue Growth Rate in Injectable Drug Delivery Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
  • Global Pulmonary Drug Delivery Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 143
    According to our LPI (LP Information) latest study, the global Pulmonary Drug Delivery Systems market size was valued at US$ 2979.8 million in 2023. With growing demand in downstream market, the Pulmonary Drug Delivery Systems is forecast to a readjusted size of US$ 4016.5 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Pulmonary Drug Delivery Systems market. Pulmonary Drug Delivery Systems are expected to show s......
  • Global Metered Dose Inhalers Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 88
    The Metered Dose Inhalers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metered Dose Inhalers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides pr......
  • Global Drug Delivery Devices Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Drug Delivery Devices market size was valued at US$ 40490 million in 2023. With growing demand in downstream market, the Drug Delivery Devices is forecast to a readjusted size of US$ 57290 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drug Delivery Devices market. Drug Delivery Devices are expected to show stable growth in the future market. However......
  • Global Nebulizers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Nebulizers market size was valued at US$ 844.1 million in 2023. With growing demand in downstream market, the Nebulizers is forecast to a readjusted size of US$ 1194.4 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Nebulizers market. Nebulizers are expected to show stable growth in the future market. However, product differentiation, reducing costs, ......
  • Global Inhalation Therapy Nebulizer Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Inhalation Therapy Nebulizer market size was valued at US$ 1111.6 million in 2023. With growing demand in downstream market, the Inhalation Therapy Nebulizer is forecast to a readjusted size of US$ 1755.2 million by 2030 with a CAGR of 6.7% during review period. The research report highlights the growth potential of the global Inhalation Therapy Nebulizer market. Inhalation Therapy Nebulizer are expected to show stable growth......
  • Global Medical Nebulizer Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Medical Nebulizer market size was valued at US$ 1082.4 million in 2023. With growing demand in downstream market, the Medical Nebulizer is forecast to a readjusted size of US$ 1836.1 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Medical Nebulizer market. Medical Nebulizer are expected to show stable growth in the future market. However, product diff......
  • Global Intrathecal Pumps Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 75
    According to our LPI (LP Information) latest study, the global Intrathecal Pumps market size was valued at US$ 263.7 million in 2023. With growing demand in downstream market, the Intrathecal Pumps is forecast to a readjusted size of US$ 345.7 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Intrathecal Pumps market. Intrathecal Pumps are expected to show stable growth in the future market. However, product differ......
  • Global Intranasal Drug Delivery Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Intranasal Drug Delivery Devices market size was valued at US$ 1118.1 million in 2023. With growing demand in downstream market, the Intranasal Drug Delivery Devices is forecast to a readjusted size of US$ 2382.3 million by 2030 with a CAGR of 11.4% during review period. The research report highlights the growth potential of the global Intranasal Drug Delivery Devices market. Intranasal Drug Delivery Devices are expected to s......
  • Global Drug Delivery Devices Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 156
    According to our (Global Info Research) latest study, the global Drug Delivery Devices market size was valued at USD 42590 million in 2023 and is forecast to a readjusted size of USD 58700 million by 2030 with a CAGR of 4.7% during review period. Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs